Effect of Early Initiation of Evolocumab and Combination Lipid-lowering Agent on Lipid Profiles Changes in Patients With Acute Coronary Syndrome Undergoing percuTAneous coronaRy Intervention: a Prospective, Randomized Controlled Trial
Latest Information Update: 18 Mar 2025
At a glance
- Drugs Evolocumab (Primary) ; Ezetimibe (Primary) ; Rosuvastatin (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms C-STAR
Most Recent Events
- 13 Mar 2025 Status changed from active, no longer recruiting to completed.
- 09 Jan 2025 Planned primary completion date changed from 1 Nov 2025 to 1 Mar 2025.
- 09 Jan 2025 Status changed from recruiting to active, no longer recruiting.